Insider Trading June 3, 2026 04:11 PM

Insider Activity and Mixed Signals Emerge for Enact Holdings Following Executive Stock Sale

Analysis covers executive selling activity, recent earnings performance, and varying analyst forecasts for ACT.

By Jordan Park ACT

The latest disclosed insider trading activity involves the sale of shares by an executive at Enact Holdings, Inc. (NASDAQ:ACT). This transaction occurs against a backdrop of mixed financial results reported in the first quarter of 2026, where earnings beat consensus estimates but revenue fell short of projections. The company maintains a significant market capitalization and offers investors a defined dividend yield.

Insider Activity and Mixed Signals Emerge for Enact Holdings Following Executive Stock Sale
ACT

Key Points

  • <li class="text-gray-700"><strong>Mixed Financial Signals:</strong> The company reported Q1 2026 adjusted EPS of $1.21, surpassing the consensus estimate ($1.18). However, this positive beat was offset by revenue falling short of projections, coming in at $312.07 million versus an expected $315.08 million.</li>
  • <li class="text-gray-700"><strong>Analyst Downgrade and Rating:</strong> BofA Securities maintained a Buy rating on Enact Holdings but lowered its price target from $49 to $46, citing higher-than-expected losses as the primary reason for the adjustment.</li>
  • <li class="text-gray-700"><strong>Insider Activity Context:</strong> Executive Vice President and COO Brian Gould sold 23,000 shares on June 1, 2026, totaling $947,204, which occurs while the stock has seen a 20.5% return over the past year but is deemed overvalued by some valuation models.</li>

Recent disclosures reveal that Brian Gould, who holds the titles of Executive Vice President and Chief Operations Officer at Enact Holdings, Inc. (NASDAQ:ACT), conducted a transaction involving the sale of common stock shares on June 1, 2026. Mr. Gould disposed of a total quantity of 23,000 shares during this period.

The specific terms of the disposition indicate that the sale was executed at a price point of $41.1828 per share, resulting in a total transaction value of $947,204. Following the completion of this stock disposal, Mr. Gould's direct ownership stake in Enact Holdings common stock was reduced to 22,291 shares.


This reported insider selling takes place while various market metrics provide a nuanced view of the company’s valuation and performance. Over the preceding year, Enact shares have demonstrated a cumulative return of 20.5%. However, analysis provided by InvestingPro suggests that, relative to its calculated Fair Value, the stock is currently assessed as being overvalued. Despite these considerations, the company maintains a substantial market capitalization of $5.65 billion and provides investors with an established dividend yield of 2.33%.


Further complicating the investment landscape are Enact Holdings Inc.'s recently reported first-quarter 2026 earnings figures. In this quarter, the company announced adjusted earnings per share (EPS) totaling $1.21. This figure exceeded the consensus estimate of $1.18 for the period.

However, the overall financial picture presented a mix of outcomes. While the EPS demonstrated an improvement over expectations, the company's reported revenue for the quarter was $312.07 million. This figure registered slightly below the anticipated revenue level of $315.08 million. The combination of an earnings beat coupled with a revenue shortfall led to varied reactions among market participants.


In response to these developments, BofA Securities maintained its Buy rating on Enact Holdings. Nevertheless, the firm adjusted its price target downward, moving it from $49 to $46. This reduction in the price target was attributed by BofA Securities to higher-than-expected losses reported by the company. These recent corporate actions and financial disclosures underscore the current state of Enact Holdings’ financial health and market perception.

Market observers, including analysts and institutional investors, continue to closely monitor both Enact Holdings' future earnings results and its revenue streams as they await further data points regarding the company's trajectory.


Risks

  • <li class="text-gray-700"><strong>Revenue Shortfall:</strong> The reported revenue of $312.07 million was below the anticipated $315.08 million, indicating potential operational or market headwinds that could impact future performance.</li>
  • <li class="text-gray-700"><strong>Increased Losses:</strong> BofA Securities specifically cited higher-than-expected losses when adjusting its price target downward, suggesting concerns about the company's cost structure or profitability management.</li>
  • <li class="text-gray-700"><strong>Valuation Concerns:</strong> Despite a 20.5% yearly return, InvestingPro analysis suggests that Enact shares are currently overvalued relative to their calculated Fair Value, posing valuation risk for potential investors.</li>

More from Insider Trading

Rackspace Technology Executive Offloads Shares to Cover Tax Obligations Amid Stock Surge Jun 4, 2026 Fermi Inc. Executive Unloads $1M in Shares Amid Ongoing Corporate Restructuring Jun 4, 2026 Veracyte Executive Sells Nearly $700K in Shares Amid Product Rollouts and Analyst Upgrades Jun 4, 2026 Veracyte Executive Traces Share Disposition Amid Clinical Milestones and Valuation Scrutiny Jun 4, 2026 Veracyte CFO Executes $177K Stock Sale Amid Clinical Trial Updates and Analyst Revisions Jun 4, 2026